Tirapazamine-cisplatin: the synergy.

Open Access

Publisher Website

1 January 1998

journal article
review article
Published by Springer Nature in British Journal of Cancer

Vol. 77 (4) , 15-17
https://doi.org/10.1038/bjc.1998.431

Abstract

No abstract available

Keywords

This publication has 2 references indexed in Scilit:

Phase II study of the combination of the novel bioreductive agent, tirapazamine, with cisplatin in patients with advanced non-small-cell lung cancer
Annals of Oncology, 1997
Tumor-specific, schedule-dependent interaction between tirapazamine (SR 4233) and cisplatin.
1993